Skip to main content

Peer Review reports

From: Current clinical practice and physicians’ insights on Chinese patients with advanced non-small cell lung cancer habouring epidermal growth factor receptor 20 insertion mutation

Original Submission
11 Sep 2023 Submitted Original manuscript
8 Oct 2023 Reviewed Reviewer Report
3 Jul 2024 Reviewed Reviewer Report
25 Jul 2024 Author responded Author comments - Yan Xu
Resubmission - Version 2
25 Jul 2024 Submitted Manuscript version 2
28 Jul 2024 Reviewed Reviewer Report
8 Aug 2024 Reviewed Reviewer Report
10 Aug 2024 Author responded Author comments - Yan Xu
Resubmission - Version 3
10 Aug 2024 Submitted Manuscript version 3
Publishing
12 Aug 2024 Editorially accepted
23 Aug 2024 Article published 10.1186/s12885-024-12797-3

You can find further information about peer review here.

Back to article page